Yahoo Web Search

Search results

1. • 

     Moderna and Pfizer In Talks With U.S. To Make a Bird Flu Vaccine

     Barrons.com· 3 days ago

     According to a federal registry of clinical trials, the trial should be completed in July. The...

2. • 

     ASCO24: An early look at cancer drug study results

     BioPharma Dive via Yahoo Finance· 3 days ago

     Clinical trial abstracts posted Thursday ahead of this year’s ASCO meeting give a peek at anticipated datasets from Immunocore, Merus, J&J and Merck &...

3. • 

     Neurotoxin referred to as ‘vegan Botox’ used to minimize fine lines, wrinkles in adults as young as...

     Fox News via Yahoo News· 2 days ago

     Medical spa personnel are testing and using Daxxify, the latest FDA-approved injectable neurotoxin...

4. • Oncolytics Biotech® ASCO Abstracts Highlight Pelareorep's Potential in Pancreatic Cancer and...

     FOX 23 News Albany· 2 days ago

     One is a trial-in-progress abstract discussing cohort 5 of the GOBLET study, which will evaluate the combination of pelareorep and modified FOLFIRINOX (mFOLFIRINOX) with and ...

5. • 

     Are 'deaths of despair' really more common for white Americans? A UCLA report says no

     LA Times via Yahoo News· 5 days ago

     But after roughly a decade, researchers at UCLA and elsewhere have begun to dismantle this idea. In...

6. • 

     ENDRA meets with FDA on liver device clinical trial design By Investing.com

     Investing.com· 6 days ago

     Food and Drug Administration (FDA) regarding its TAEUS liver device. The meeting, which took place...

7. • 

     Henry A. Homburger

     Post-Bulletin· 3 days ago

     Henry A. Homburger, M.D. was born in Detroit, MI, on July 20, 1946, to Abner and Ingrid (née Anderson) Homburger. Henry graduated with distinction from...

8. • Neuralink gets FDA approval for second brain implant patient: WSJ

     Teslarati· 6 days ago

     Elon Musk’s brain implant company has gained approval to begin human trials on a second clinical patient, after the first patient has shared some words ...

9. • TREMFYA® (guselkumab) QUASAR Maintenance Study in UC met its primary endpoint and all major...

     FOX 23 News Albany· 6 days ago

     ...Johnson & Johnson today announced the first data from the Phase 3 QUASAR Maintenance Study (Abstract #759) that showed 50.0 percent (p<0.001) of patients with moderately to severely active ulcerative colitisa (UC...45.2 percent (p<0.001) of patients receiving SC TREMFYA® 100 mg every eight weeks...

10. • 

      CDC study says 1 in 9 children have ADHD

      Deseret News via Yahoo News· 3 days ago

      Although the condition may begin during childhood, it can continue through adolescence and adulthood. Signs of ADHD include a short attention span or...